What is the step therapy approach for abortive migraine treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Abortive Migraine Step Therapy

For mild to moderate migraine attacks, start with oral NSAIDs (ibuprofen 400-800 mg, naproxen sodium 275-550 mg) or aspirin-acetaminophen-caffeine combination; for moderate to severe migraines or those failing NSAIDs, escalate to triptans as first-line therapy. 1

Step 1: Mild to Moderate Migraine

Initial therapy should prioritize:

  • Aspirin-acetaminophen-caffeine combination (strong recommendation with number needed to treat of 9 for pain freedom at 2 hours) 1
  • NSAIDs as monotherapy: Ibuprofen 400-800 mg, naproxen sodium 275-550 mg, or aspirin 650-1,000 mg 1
  • Isometheptene combinations (isometheptene-acetaminophen-dichloralphenazone) for milder attacks 1

Critical caveat: Acetaminophen alone is NOT recommended for migraine—it must be combined with aspirin and caffeine to be effective 1

Step 2: Moderate to Severe Migraine or NSAID Failures

Escalate to migraine-specific agents:

  • Triptans (first-line for this severity): Sumatriptan, rizatriptan, naratriptan, zolmitriptan, eletriptan, almotriptan 1

    • Rizatriptan achieves 33% pain freedom at 2 hours in adults 2
    • Contraindicated in: Vascular disease, uncontrolled hypertension, hemiplegic migraine 3, 4
  • Gepants (newer option): Ubrogepant or rimegepant with number needed to treat of 13 for pain freedom at 2 hours 1

  • Dihydroergotamine (DHE) for selected patients 1

    • Warning: Requires cardiovascular screening in patients with CAD risk factors; contraindicated with potent CYP3A4 inhibitors 3
  • Ergotamine derivatives (less preferred due to side effect profile) 1

Step 3: Migraine with Nausea/Vomiting

Use non-oral routes of administration:

  • Intranasal or subcutaneous triptans 1, 4
  • Intranasal DHE 1
  • Parenteral ketorolac 60 mg IM 1

Add antiemetic adjuncts:

  • Metoclopramide 10 mg IV or oral (improves gastric motility and provides synergistic analgesia) 1
  • Prochlorperazine 25 mg oral or suppository (can relieve headache pain directly) 1

Step 4: Severe Refractory Migraine

For attacks not responding to above treatments:

  • Greater occipital nerve block (weak recommendation for abortive use) 1
  • Rescue medications: Self-administered options to avoid emergency department visits 1
  • Lasmiditan (5-HT1F agonist with robust efficacy but driving restrictions; number needed to harm of 4 for adverse effects) 1

Emergency department options:

  • Intravenous antiemetics with or without IV DHE 4
  • Dexamethasone as adjunct to prevent short-term recurrence 4

Critical Medications to AVOID or Limit

Strongly discouraged for routine use:

  • Opioids (meperidine, butorphanol): Risk of dependency, rebound headaches, and loss of efficacy 1, 5, 4
  • Butalbital-containing analgesics: Same concerns as opioids 1, 5
  • Acetaminophen monotherapy: Ineffective for migraine 1

Monitor closely if used: Limit opioids to 50-150 mg meperidine IM/IV or butorphanol 1 mg intranasal spray (maximum 2 days/week) only when all other options exhausted 1

Treatment Timing and Frequency Principles

Administer medication as early as possible after symptom onset to maximize efficacy 1, 4

Avoid medication overuse headache:

  • NSAIDs: Limit to <15 days/month 5
  • Triptans: Limit to <10 days/month 5
  • Monitor all abortive medications for overuse patterns 1

Special Population: Pregnancy

First-line: Acetaminophen 1,000 mg (safest option) 5

Second-line: Ibuprofen (second trimester ONLY) 5

Avoid: Ergotamine derivatives, DHE, topiramate, valproate, gepants (insufficient safety data) 5, 3

Sumatriptan: May be used sporadically under strict specialist supervision when other treatments fail 5

Adjunctive Strategies

Enhance treatment success with:

  • Caffeine as adjunct (improves analgesic efficacy) 1
  • Sleep induction for selected patients 1
  • Hydration, regular meals, consistent sleep patterns 5
  • Trigger identification and avoidance 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of acute migraine headache.

American family physician, 2011

Guideline

Migraine Management During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.